Published in Research

Study identifies Sjögren’s symptom-based patient groups

This is editorially independent content
8 min read

Dry eye and dry mouth may be defining features of Sjögren’s disease, but they don't necessarily tell clinicians how heavily the disease is affecting a particular patient.

A new study suggests looking at the symptoms occurring alongside dryness may provide a fuller picture, with researchers identifying four patient groups ranging from predominantly sicca symptoms to widespread multisystem disease—along with substantial differences in psychological and functional burden.

First, why look beyond dryness?

Sjögren’s is a systemic autoimmune disease characterized by exocrine gland dysfunction and dry eye and dry mouth are among its hallmark features.

But its clinical presentation can vary considerably. Patients may also experience fatigue, musculoskeletal pain, cognitive difficulties, psychological distress and systemic manifestations.

And that disconnect can extend to the eye.

Explain, please.

Previous research found that ocular surface staining did not correlate with dry eye symptom severity or quality-of-life measures in patients with primary Sjögren’s, highlighting why objective ocular findings alone may not capture the patient's overall disease experience.

Researchers have also identified symptom-based Sjögren’s subgroups before, including groups characterized by different combinations of dryness, pain, fatigue, anxiety and depression.

Which brings us to the current study: Could looking at how symptoms occur together tell us something about patients' functional burden and what they need from their healthcare?

So, what did researchers do?

They conducted a secondary analysis of cross-sectional data from an online survey conducted between June and September 2022.

  • Notably: Patients helped co-design the survey and contributed to the selection and refinement of symptoms used in the analysis.

And while the original survey contained a 47-item symptom checklist, researchers ultimately used 24 symptoms in a latent class analysis (LCA)—a statistical approach designed to identify groups based on patterns within the data.

The team then compared the resulting groups using measures including the EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and Hospital Anxiety and Depression Scale (HADS).

And who was included?

The analysis included 296 adults who self-identified as living with Sjögren’s. Eligibility included those with a formal diagnosis as well as people reporting symptoms consistent with the condition.

Most participants reported having a formal Sjögren’s diagnosis.

Age, gender and diagnostic status weren't used to create the classes. Instead, patients were grouped according to the presence or absence of the 24 symptoms.

… so what patient groups emerged?

Researchers found four symptom-based groups, with dryness common across all four:

  • Class 1: Sicca-predominant, low multisystem burden (39.5%)
    • Primarily dry eye and dry mouth, with comparatively lower fatigue, pain and psychological distress
  • Class 2: High fatigue-dryness with elevated anxiety and depression (23.7%)
    • Prominent fatigue and dryness alongside musculoskeletal symptoms and greater psychological burden
  • Class 3: Mixed musculoskeletal-depressive burden with functional impact (17.9%)
    • Prominent joint and muscle pain, fatigue and cognitive symptoms such as brain fog, along with substantial psychological distress
  • Class 4: Multisystem, high-severity (18.9%)
    • Widespread symptoms spanning dryness, fatigue, musculoskeletal, neurological and cognitive domains

Interestingly, age, gender and diagnosis status didn't differ significantly across the groups; symptom burden did.

And did those differences affect daily life?

Yes, they did. The proportion of patients reporting that they were unable to work because of illness increased considerably across the four groups:

  • Class 1: 3.4%
  • Class 2: 21.4%
  • Class 3: 26.4%
  • Class 4: 33.9%

Overall symptom burden, anxiety and depression also differed significantly among the groups.

Class 3 had the highest proportion of participants meeting HADS thresholds for anxiety (81.1%) and depression (75.5%). Meanwhile, Class 4 carried a substantial burden across multiple physical and psychological domains.

Notably: The group with the broadest physical symptom profile wasn't necessarily the one with the greatest psychological burden.

Any limitations to keep in mind?

A few …

First, this was a cross-sectional analysis, meaning researchers couldn't determine whether patients remain in the same symptom group over time or transition between groups as their disease changes.

Recruitment through patient advocacy networks may also have introduced selection bias by attracting people with greater symptom burden or stronger engagement with patient organizations.

Plus: The study didn't include biological markers, so researchers couldn't determine whether the symptom-defined groups corresponded with different immunological profiles or organ-specific disease measures.

And because eligibility intentionally included both formally diagnosed patients and people with symptoms consistent with Sjögren’s, some participants may not have met established classification criteria.

  • However, a sensitivity analysis restricted to participants reporting a formal diagnosis produced a broadly similar class structure.

So, what could this mean clinically?

The researchers suggest that examining patterns of symptom co-occurrence may reveal information that overall disease-severity measures alone can miss.

That's particularly relevant because Sjögren’s currently lacks a reliable biological marker that can neatly stratify patients according to their multidimensional symptom burden.

In clinical settings, the authors suggested that multidimensional patient-reported outcome measures could help identify people with more complex symptom profiles, even when overall scores appear similar.

  • For example: They noted that patients with a fatigue-psychological burden profile may warrant consideration of integrated rheumatology and mental health support, while predominantly sicca-burdened patients may benefit from more targeted ocular and oral care.

Anything else? What did patients say they needed?

As symptom burden increased, so did the urgency patients placed on several healthcare needs.

The proportion reporting an urgent need for effective treatments increased from 56.4% in Class 1 to 83.9% in Class 4.

For better diagnostic testing, the highest-burden group reached 67.9%.

However, one concern stretched across the symptom spectrum: better education among healthcare professionals.

  • Urgent need for improved doctor education increased from 68% in Class 1 to 93% in Class 4, while the corresponding figures for education of other healthcare professionals increased from 62% to 91%.

In other words: Even patients in the lowest-burden group saw professional education as an important unmet need.

Take home.

Sjögren’s didn't present as one uniform symptom profile in this analysis.

And while the findings don't establish four biological Sjögren’s subtypes or provide a treatment algorithm, they do suggest that considering which symptoms occur together may reveal clinically relevant differences that overall severity scores or dryness assessments alone don't capture.

For eyecare providers, that's worth remembering in a disease so closely associated with dry eye: Ocular dryness may be one part of a considerably larger symptom burden.